P3 Health Partners Inc. (PIII) Dividend History

P3 Health Partners Inc. (PIII) is a healthcare company focused on value-based primary care. It operates a network of primary care clinics that aim to improve patient health outcomes through coordinated, personalized care models, often emphasizing preventative health and integration with specialty services. The company seeks to enhance healthcare quality while reducing costs for payers and patients.

2045 W Grand Ave Ste B, Chicago, IL, 60612-1577
Phone: 312-822-8897
Website:

Dividend History

P3 Health Partners Inc. currently does not pay dividends

Company News

  • Wolf Haldenstein Adler Freeman & Herz LLP is investigating claims against P3 Health Partners, Inc. (PIII) for allegedly making false and misleading statements or omissions in violation of federal securities laws. The investigation is triggered by P3's disappointing financial results and a civil investigative demand from the Department of Justice.

    GlobeNewswire Inc.
  • Kuehn Law, a shareholder litigation law firm, is investigating potential self-dealing by officers and directors of P3 Health Partners Inc. (PIII). Shareholders may be entitled to damages and corporate governance reforms.

    GlobeNewswire Inc.
  • P3 Health Partners is collaborating with healthcare providers in five states, providing assistance for compensation. See why PIII stock is a Buy.

    Seeking Alpha
  • P3 Health Partners (PIII) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Zacks Investment Research
    Featured Companies: HIMS
  • Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24 insurance revenue guidance. Clover Health Investments reported quarterly sales of $510.3 million which beat the analyst consensus estimate of $480.25 million by 6.26% and represents a 43.22% decrease over sales of $898.79 million the same period last year. Clover Health Investments shares climbed 11.2% to $0.8537 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Gaxos.ai Inc. (NASDAQ: GXAI) shares jumped 128.9% to $12.18 after the company announced it acquired the rights to use certain AI-enabled technology from Ultiself. Veritone, Inc. (NASDAQ: VERI) gained 52.4% to $2.6076 following strong sales results. NuCana plc (NASDAQ: NCNA) gained 50.2% to $0.5869 after the company was granted a US Patent for "Phosphoramidate Derivatives For Use In The Treatment Of Cancer; Especially In The Treatment Where The Patient Shows Resistance." The Beauty Health Company (NASDAQ: SKIN) rose 31.9% to $4.7350 after the company reported better-than-expected fourth-quarter revenue results. Arq, Inc. (NASDAQ: ARQ) gained 28.3% to $4.4522 after the company reported upbeat fourth-quarter results. MicroCloud Hologram Inc. (NASDAQ: HOLO) jumped 26.6% to $6.19. Kintara Therapeutics, Inc. (NASDAQ: KTRA) shares gained 26.2% to $0.1055. Nature's Sunshine Products, Inc. (NASDAQ: NATR) jumped 24.7% to $21.47 after the company reported better-than-expected fourth-quarter adjusted EPS results and issued FY24 net sales guidance. Heron Therapeutics, Inc. (NASDAQ: HRTX) gained 24.7% to $2.9428 after the company reported better-than-expected fourth-quarter adjusted EPS results and issued FY24 revenue guidance. Also, Needham maintained a Buy rating on the stock and raised its price target from $4 to $5. Li-Cycle Holdings Corp. (NASDAQ: LICY) shares gained 23.2% to $0.7233. Li-Cycle shares jumped 46% on Tuesday after the ...

    Benzinga
Dividend data last updated 06/07/2025 20:28:37 UTC